| HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to increase transparency and lower prescription drug prices since President Trump released his American Patients First blueprint in a Rose Garden ceremony a year ago. The blueprint offered nearly 30 policy recommendations to modernize payment policies, including bringing down out-of-pocket costs for patients. Just last week, HHS issued a final rule to give patients and doctors more tools to monitor and control costs in Medicare. For example, after a start-up period, Medicare Part D plans will be required to provide doctors and other prescribers access to price information for different prescription drugs when they are writing the script. |
American Healthcare Choices
A Project of the Galen Institute
HHS Marches Forward To Enhance Drug Price Transparency
You are here:
